Clinical trials

SOLAR: Copper Cu64 PSMA I&T Injection in Patients with Histologically Proven Metastatic Prostate Cancer

Condition

Histologically Proven Metastatic Prostate Cancer

ClinicalTrials.gov identifier

NCT05653856

Interventions

Intervention Type: Drug
Intervention Name: Copper Cu64 PSMA I&T
Intervention Description: Intravenous radionuclide used for PET imaging

Curium Protocol Number

CURCu64PSM0001

Phase

Phase 1/2

Trial Status

Trial Complete

Protocol Title

A Multi-Center, Open-Label, Randomized Phase 1/2 Study of Copper Cu64 PSMA I&T Injection in Patients with Histologically Proven Metastatic Prostate Cancer.

Purpose

The purpose of this study is to evaluate the safety, biodistribution, and image quality of Copper Cu64 PSMA I&T Injection to detect metastatic prostate cancer in PET imaging.